Rheumatoid Arthritis Trial, Recruiting NCT06492200 Sponsor: Wuerzburg University Hospital Condition: Rheumatoid Arthritis
Back to Rheumatoid Arthritis

Rheumatoid Arthritis Trial, Recruiting

NCT06492200
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have been diagnosed with Rheumatoid Arthritis based on the 2010 ACR (American College of Rheumatology) criteria
  • People who understand what the study involves and are willing to sign a written agreement to take part

Who may not be able to join:

  • People who are under 18 years of age
  • People who are not able to give informed consent to participate
  • People who do not have sufficient knowledge of the German language
  • People who have a chronic inflammatory bowel disease (such as Crohn's disease or ulcerative colitis)
  • People who have liver cirrhosis (serious scarring of the liver)
  • People who have a history of mechanical ileus (a bowel blockage caused by a physical obstruction)
  • People who have had changes made to their digestive tract, such as those who have a stoma (an opening in the abdomen used to redirect the bowel)
  • People who have used antibiotics in the three months before joining the study
  • People who have used ground psyllium husks (a type of fibre supplement) in the four weeks before joining the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Eva C Schwaneck, M.D., University Wuerzburg

Phone: +49 40 1818 81 8343

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Wuerzburg University Hospital
Registry
ClinicalTrials.gov
Start date
1 June 2024
Est. completion
1 June 2026

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Disease Activity Score 28 (DAS28); C-Reactive Protein (CRP) Level; Short-Chain Fatty Acids (SCFA) Levels in Stool; Body Weight

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov